AKEBIA THERAPEUTICS, INC. (AKBA) Operating cash flow 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$68.0MFY2025 · since FY2016: $57.9M → $68.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $68.0M | +267.2% |
| FY2024 | -$40.7M | -73.9% |
| FY2023 | -$23.4M | +68.0% |
| FY2022 | -$73.2M | +71.1% |
| FY2021 | -$253.0M | -129.2% |
| FY2020 | -$110.4M | +57.1% |
| FY2019 | -$257.4M | -164.1% |
| FY2018 | -$97.5M | -73.6% |
| FY2017 | -$56.2M | -197.0% |
| FY2016 | $57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice